ストックスクリーナーアプリを入手
47.22
0.56%
0.21
前日終値:
$47.01
開ける：
$47.12
24時間の取引高:
169.80K
Relative Volume:
0.15
時価総額：
$10.24B
収益：
$2.04B
当期純損益:
$373.39M
株価収益率:
27.84
EPS:
1.6961
ネットキャッシュフロー:
$495.96M
1週間 パフォーマンス:
+5.12%
1か月 パフォーマンス:
+0.56%
6か月 パフォーマンス:
-0.54%
1年 パフォーマンス:
+2.27%
1日の値動き範囲:
$47.08
$47.57
1週間の範囲:
$44.71
$47.57
52週間の値動き範囲:
$37.74
$51.88
Qiagen Nv Stock (QGEN) Company Profile
QGEN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
47.23 | 10.19B | 2.04B | 373.39M | 495.96M | 1.6961 |
|
TMO
Thermo Fisher Scientific Inc
|
621.52 | 233.21B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
236.74 | 167.12B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
722.89 | 56.44B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
147.88 | 41.84B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
245.96 | 40.96B | 15.90B | 1.28B | 2.21B | 7.2842 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-06-24 | 開始されました | Barclays | Overweight |
| 2025-04-04 | ダウングレード | Redburn Atlantic | Buy → Neutral |
| 2025-02-19 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2025-01-06 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2024-12-10 | アップグレード | Jefferies | Hold → Buy |
| 2024-10-17 | ダウングレード | HSBC Securities | Buy → Hold |
| 2024-06-27 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2023-12-19 | 開始されました | Wells Fargo | Equal Weight |
| 2023-12-13 | 開始されました | Wolfe Research | Peer Perform |
| 2023-12-07 | アップグレード | Goldman | Neutral → Buy |
| 2023-09-12 | 開始されました | Robert W. Baird | Outperform |
| 2023-05-23 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-18 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-01-18 | アップグレード | DZ Bank | Hold → Buy |
| 2021-10-15 | 再開されました | Cowen | Market Perform |
| 2021-10-14 | 開始されました | Redburn | Buy |
| 2021-07-14 | ダウングレード | Kepler | Buy → Hold |
| 2021-06-03 | 開始されました | Goldman | Neutral |
| 2020-10-06 | 再開されました | BofA Securities | Buy |
| 2020-09-28 | アップグレード | Kepler | Hold → Buy |
| 2020-08-24 | アップグレード | Citigroup | Neutral → Buy |
| 2020-08-20 | 再開されました | JP Morgan | Overweight |
| 2020-08-17 | アップグレード | Berenberg | Hold → Buy |
| 2020-08-14 | アップグレード | Deutsche Bank | Hold → Buy |
| 2020-08-14 | アップグレード | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-04 | ダウングレード | Berenberg | Buy → Hold |
| 2020-01-08 | 開始されました | Wells Fargo | Equal Weight |
| 2020-01-07 | 開始されました | Citigroup | Neutral |
| 2019-12-26 | 再開されました | BofA/Merrill | Underperform |
| 2019-11-15 | 開始されました | Stifel | Hold |
| 2019-11-14 | アップグレード | Evercore ISI | In-line → Outperform |
| 2019-11-14 | アップグレード | JP Morgan | Underweight → Overweight |
| 2019-11-14 | アップグレード | Kepler | Reduce → Hold |
| 2019-10-17 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2019-10-09 | ダウングレード | Kepler | Hold → Reduce |
| 2019-10-08 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2019-10-08 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2019-10-08 | ダウングレード | JP Morgan | Neutral → Underweight |
すべてを表示
Qiagen Nv (QGEN) 最新ニュース
Qiagen NV To Go Ex-Dividend On January 8th, 2026 With 2.29 USD Dividend Per Share And 19-for-20 Reverse Stock Split - 富途牛牛
Gateway Investment Advisers LLC Takes Position in Qiagen N.V. $QGEN - MarketBeat
Generali Asset Management SPA SGR Increases Holdings in Qiagen N.V. $QGEN - MarketBeat
Qiagen and Gencurix partner for oncology tests - MSN
Weekly Trades: Why Qiagen NV Common Shares stock trades below fair valueJuly 2025 Momentum & Low Risk High Win Rate Stock Picks - moha.gov.vn
Qiagen N.V. (NYSE:QGEN) is a favorite amongst institutional investors who own 82% - Yahoo Finance
Qiagen N.V.: Quiet Accumulation Or Fading Momentum? A Deep Look At The Stock Behind Molecular Diagno - AD HOC NEWS
Allspring Global Investments Holdings LLC Raises Holdings in Qiagen N.V. $QGEN - MarketBeat
Reproductive Genetics Market Size to Reach USD 16.67 Billion in 2032 Amid Increasing Demand for Genetic Testing - GlobeNewswire Inc.
Burney Co. Purchases Shares of 38,699 Qiagen N.V. $QGEN - MarketBeat
Qiagen sees synthetic share repurchase completed in January - MSN
Qiagen (NYSE:QGEN) Shares Set to Reverse Split on Thursday, January 8th - MarketBeat
Qiagen N.V. (NYSE:QGEN) Given Average Rating of "Hold" by Analysts - MarketBeat
Qiagen NV To Carry Out 19-for-20 Reverse Stock Split On January 8th, 2026 - 富途牛牛
Qiagen N.V. $QGEN Shares Sold by Voya Investment Management LLC - MarketBeat
Qiagen (NYSE:QGEN) Rating Increased to Buy at Wall Street Zen - MarketBeat
Growth Value: Is ONE Gas Inc OG9 stock attractive for dividend growthWeekly Stock Report & Weekly High Momentum Picks - moha.gov.vn
What Wall Street predicts for Qiagen N.V. stock priceQuarterly Profit Summary & Daily Growth Stock Investment Tips - Улправда
How Qiagen N.V. stock performs in rising dollar environment2025 Year in Review & Stepwise Entry and Exit Trade Signals - bolumsonucanavari.com
Qiagen’s US$500 Million Synthetic Buyback Might Change The Case For Investing In Qiagen (QGEN) - Sahm
What sentiment indicators say about Qiagen N.V. stockTake Profit & Safe Capital Growth Tips - Улправда
Whale Trades: How buybacks impact Qiagen N.V. stock valueJuly 2025 Short Interest & Safe Entry Momentum Tips - Улправда
Can Qiagen N.V. stock beat market expectations this quarter2025 EndofYear Setup & Expert Approved Trade Ideas - DonanımHaber
Can Qiagen N.V. Common Shares stock sustain revenue momentum2025 Support & Resistance & Real-Time Chart Breakout Alerts - DonanımHaber
Why Qiagen N.V. stock is recommended by analysts2025 Trade Ideas & Long-Term Growth Stock Strategies - Bölüm Sonu Canavarı
Aug Sectors: How interest rate cuts could boost Qiagen N.V. stockM&A Rumor & Smart Allocation Stock Reports - Улправда
Trend Review: Can Qiagen NV stock maintain growth trajectoryJuly 2025 Intraday Action & Stepwise Trade Execution Plans - moha.gov.vn
[6-K] QIAGEN N.V. Current Report (Foreign Issuer) | QGEN SEC FilingForm 6-K - Stock Titan
Published on: 2025-12-19 07:09:16 - Улправда
Published on: 2025-12-19 04:35:20 - Улправда
Qiagen Details on Completion of $500 Million Synthetic Share Repurchase - 富途牛牛
QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $500 Mi - PharmiWeb.com
Qiagen price target raised to $55 from $53 at Barclays - MSN
QIAGEN to return $500 million to shareholders through share repurchase By Investing.com - Investing.com Nigeria
QIAGEN Announces Details For Completion Of Synthetic Share Repurchase Of Up To Approximately $500 Million >QGEN - 富途牛牛
QIAGEN to return $500 million to shareholders through share repurchase - Investing.com
Qiagen announces details for completion of synthetic share repurchase of up to approximately $500 mln - marketscreener.com
QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $500 Million - marketscreener.com
What analyst consensus says on Qiagen N.V. stock2025 Retail Activity & Smart Allocation Stock Tips - ulpravda.ru
QIAGEN NV receives notification on voting rights from AFM - MSN
Does Qiagen Offer Long Term Value After Recent Precision Medicine Investments? - Sahm
Key facts: Goldman Sachs Reports Holdings in QIAGEN, American Axle, Qualcomm - TradingView — Track All Markets
Tangible book value per share of QIAGEN NV – EUROTLX:4QGEN - TradingView — Track All Markets
Barclays Maintains Qiagen N.V. (QGEN) Overweight Recommendation - Nasdaq
QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - Pressetext
AlphaValue/Baader Europe Ups Qiagen EPS Estimates on Operational Performance Beat - marketscreener.com
Morgan Stanley Maintains Qiagen NV(QGEN.US) With Hold Rating, Cuts Target Price to $49.36 - 富途牛牛
QIAGEN Announces Significant Goldman Sachs Transaction Notification - TipRanks
QIAGEN N.V. Receives Notification on Voting Rights from AFM - TipRanks
Barclays Raises Price Target for QGEN to $55.00 While Maintainin - GuruFocus
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView — Track All Markets
Qiagen Nv (QGEN) 財務データ
収益
当期純利益
現金流量
EPS
1.31%
0.67%
大文字化:
|
ボリューム (24 時間):